Clinical Trends in Asleep and Awake DBS in North America vs Europe
Objective: To compare trends and perceptions regarding Asleep and Awake deep brain stimulation (DBS) in North America (NA) and Europe (EU). Background: DBS clinical practice…Feasibility and added value of sensing feature in patients with chronic STN DBS for Parkinson’s disease
Objective: To test the feasibility and usefulness of sensing features in patients undergoing replacement of their implantable pulse generator (IPG). Background: People with Parkinson’s disease…Focused Ultrasound Thalamotomy for Tremor-Dominant Parkinson Disease – Ablation Volume and Dentatorubrothalamic Tract Overlap Does Not Predict Outcome
Objective: To report the long-term outcomes in Tremor-Dominant Parkinson Disease (TDPD) after a unilateral Focused Ultrasound (uni-FUS) thalamotomy and explore factors that may predict the…Unilateral Deep Brain Stimulation in Parkinson’s Disease: Long-term Efficacy and Bilateral Symptom Progression
Objective: To investigate the long-term efficacy of unilateral deep brain stimulation and the progression of motor symptoms on the untreated side in Parkinson's disease (PD)…Is the sebum RNA transcriptome analysis technique capable of non-invasively diagnosing Parkinson’s disease?
Objective: Our goal was to explore the potential of skin-surface lipid RNA transcriptome analysis as a diagnostic tool for Parkinson's disease. Background: Seborrheic dermatitis is…Reliability of Digital Measures in Parkinson’s Disease and Their Implications for Sample Size Calculations
Objective: Assess the reliability and measurement error of measures derived from digital health technologies (DHTs) in Parkinson’s Disease (PD) patients and estimate sample size for…Empower-PD: “An Exploratory Investigation of Accelerometer Data on Parkinson’s Patients’ Motor Symptoms and the Correlation with Quality of Life.”
Objective: To describe weekly changes in bradykinesia-score (BKS) measured on objective wearable data and assess the correlation between these changes and Quality of Life (QoL)…Evaluating the Effect of Myofascial Release on Parkinson’s Related Tremor
Objective: Parkinson’s disease (PD) is the second-fastest neurological disorders in the world. Although there is no cure, medicines, surgical treatment, and other therapies can treat…The First of Its Kind Genetics Cohort: the Black and African American Connections to Parkinson’s Disease (BLAAC PD) Study
Objective: Recruit and characterize a Black and African American (BAA) cohort to better understand Parkinson’s disease (PD). Background: A significant gap exists in our understanding…Genetic Modifiers of Age at Onset for Parkinson’s Disease in Chinese Population
Objective: This study aimed to identify novel genetic modifiers of age at onset (AAO) for Parkinson’s disease (PD) including common variants and rare variants using…
- « Previous Page
- 1
- …
- 32
- 33
- 34
- 35
- 36
- …
- 338
- Next Page »